In vivo evaluation of Axumin analogs syn- and anti-[123I] IVACBC as potential SPECT tumor imaging agents

被引：0
|
作者：
Yu, Weiping [1 ]
Goodman, Mark [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
725
引用
收藏
页数：2
相关论文
共 50 条
  • [1] In vivo evaluation of syn- and anti-[123I]IVACBC as potential SPECT tumor imaging agents
    Yu, Weiping
    Goodman, Mark M.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S349 - S349
  • [2] In vitro comparison of syn-, anti- and gem-[123I]IVACBC as potential SPECT tumor imaging agents
    Yu, Weiping
    Camp, Vernon
    Goodman, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [3] Synthesis and in vivo evaluation of gem[123I]IVACBC:: A potential SPECT tumor imaging agent.
    Yu, W
    McConathy, J
    Williams, L
    Malveaux, E
    Camp, VM
    Goodman, MM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 47P - 47P
  • [4] Development of SPECT imaging agents for the norepinephrine transporters:: [123I]INER
    Tamagnan, Gilles D.
    Brenner, Eric
    Alagille, David
    Staley, Julie K.
    Haile, Colin
    Koren, Andrei
    Early, Michelle
    Baldwin, Ronald M.
    Tarazi, Frank I.
    Baldessarini, Ross J.
    Jarkas, Nachwa
    Goodman, Mark M.
    Seibyl, John P.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 533 - 537
  • [5] In vivo evaluation of [123I]mZIENT as a SPECT radioligand for the serotonin transporter
    Batis, Jeffery
    Barret, Olivier
    Alagille, David
    Koren, Andrei O.
    Stehouwer, Jeffrey S.
    Cosgrove, Kelly
    Goodman, Mark
    Seibyl, John
    Tamagnan, Gilles
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (08) : 1137 - 1141
  • [6] STEREOSPECIFIC SYNTHESIS AND IN VITRO EVALUATION OF (S)/(R)-[123I]IVAIB FOR TUMOR IMAGING WITH SPECT
    Yu, W.
    Williams, L.
    Camp, V. M.
    Malveaux, E.
    Zhang, Z.
    Olson, J.
    Goodman, M. M.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S412 - S412
  • [7] In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker
    Cornelissen, B
    Oltenfreiter, R
    Kersemans, V
    Staelens, L
    Frankenne, F
    Foidart, JM
    Slegers, G
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (05) : 431 - 436
  • [8] Comparison of (S)- and (R)-[123I]IVAIB for breast tumor imaging with SPECT
    Yu Weiping
    Camp, Vernon M.
    Malveaux, Eugene
    Goodman, Mark M.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S412 - S412
  • [9] Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents
    Roberts, Maxine P.
    Nguyen, Vu
    Ashford, Mark E.
    Berghofer, Paula
    Wyatt, Naomi A.
    Krause-Heuer, Anwen M.
    Pham, Tien Q.
    Taylor, Stephen R.
    Hogan, Leena
    Jiang, Cathy D.
    Fraser, Benjamin H.
    Lengkeek, Nigel A.
    Matesic, Lidia
    Gregoire, Marie-Claude
    Denoyer, Delphine
    Hicks, Rodney J.
    Katsifis, Andrew
    Greguric, Ivan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6214 - 6224
  • [10] Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-,anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents
    Yu, Weiping
    Williams, Larry
    Malveaux, Eugene
    Camp, Vernon M.
    Olson, Jeffrey J.
    Goodman, Mark M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1264 - 1268
12345